Coagulation phenotypes in sepsis and effects of recombinant human thrombomodulin: an analysis of three multicentre observational studies

BACKGROUND: A recent randomised trial showed that recombinant thrombomodulin did not benefit patients who had sepsis with coagulopathy and organ dysfunction. Several recent studies suggested presence of clinical phenotypes in patients with sepsis and heterogenous treatment effects across different s...

Descripción completa

Detalles Bibliográficos
Autores principales: Kudo, Daisuke, Goto, Tadahiro, Uchimido, Ryo, Hayakawa, Mineji, Yamakawa, Kazuma, Abe, Toshikazu, Shiraishi, Atsushi, Kushimoto, Shigeki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7978458/
https://www.ncbi.nlm.nih.gov/pubmed/33741010
http://dx.doi.org/10.1186/s13054-021-03541-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7978458/
https://www.ncbi.nlm.nih.gov/pubmed/33741010
http://dx.doi.org/10.1186/s13054-021-03541-5

Ejemplares similares